Increase in SG&A expenses due to higher personnel and R&D costs
First written in FY2019. 1 of 20 entries say "Restated". Latest entry: FY2027-H1.
No other company in this theme has enough history to compare yet.
- FY2027-H1Slight increase in SG&A expenses for the interim periodAnnual report
「Selling, general and administrative expenses 4,828,570 4,875,853」
SG&A increased by ¥47 million, from ¥4,829 million in the interim period of the previous fiscal year to ¥4,876 million. - FY2026Full-year SG&A expenses decreasedAnnual report
「Total selling, general and administrative expenses 10,028,644 9,695,451」
SG&A decreased by ¥333 million, from ¥10,029 million in the previous fiscal year to ¥9,695 million. - FY2026-H1SG&A decreased in the interim periodAnnual report
「Selling, general and administrative expenses 4,978,693 4,828,570」
SG&A decreased by ¥150 million, from ¥4,979 million in the interim period of the previous fiscal year to ¥4,829 million. The decline in sales promotion expenses and other items, which had temporarily increased in the interim period of the previous fiscal year, was cited as a factor behind the increase in profit in the medical equipment business. - FY2025Full-year SG&A expenses increasedAnnual report
「Total selling, general and administrative expenses 9,571,345 10,028,644」
SG&A expenses increased by ¥457 million from ¥9,571 million in the previous fiscal year to ¥10,028 million. - FY2025-H1SG&A expenses for the interim period increasedAnnual report
「Selling, general and administrative expenses 4,651,096 4,978,693」
SG&A expenses increased by ¥328 million from ¥4,651 million in the previous interim period to ¥4,979 million. The increase included a temporary rise in promotional expenses and other costs associated with the launch of new hearing aid products. - FY2024Full-year SG&A expenses increasedAnnual report
「Total selling, general and administrative expenses 8,858,042 9,571,345」
SG&A expenses increased by ¥713 million from ¥8,858 million in the previous fiscal year to ¥9,571 million. - FY2024-Q2Cumulative SG&A expenses through the second quarter increasedAnnual report
「Selling, general and administrative expenses 4,184,087 4,651,096」
Cumulative SG&A expenses through the second quarter were ¥4,651 million, up ¥467 million from ¥4,184 million in the same period of the previous year. - FY2024-Q1SG&A expenses for the first quarter increasedAnnual report
「Selling, general and administrative expenses 2,084,656 2,317,118」
SG&A expenses increased by ¥232 million from ¥2,085 million in the same period of the previous year to ¥2,317 million. - FY2023Full-year SG&A expenses increasedAnnual report
「Total selling, general and administrative expenses 8,273,215 8,858,042」
SG&A expenses increased by ¥584 million from ¥8,273 million in the previous fiscal year to ¥8,858 million. - FY2023-Q3Cumulative SG&A expenses through the third quarter increasedAnnual report
「Selling, general and administrative expenses 6,112,919 6,426,528」
Cumulative SG&A expenses through the third quarter were ¥6,426 million, up ¥314 million from ¥6,112 million in the same period of the previous year. - FY2023-Q2Cumulative SG&A expenses through the second quarter increasedAnnual report
「Selling, general and administrative expenses 3,996,802 4,184,087」
Cumulative SG&A expenses through the second quarter were ¥4,184 million, up ¥187 million from ¥3,997 million in the same period of the previous year. - FY2023-Q1SG&A expenses for the first quarter increasedAnnual report
「Selling, general and administrative expenses 1,984,832 2,084,656」
SG&A expenses increased by approximately ¥100 million from ¥1,985 million in the same period of the previous year to ¥2,085 million. - FY2022-Q3Cumulative SG&A expenses through the third quarter increasedAnnual report
「Selling, general and administrative expenses 5,982,037 6,112,919」
Cumulative SG&A expenses through the third quarter were ¥6,112 million, up ¥131 million from ¥5,982 million in the same period of the previous year. - FY2021Full-year SG&A expenses decreasedAnnual report
「Total selling, general and administrative expenses 8,576,807 8,007,314」
SG&A expenses decreased by ¥569 million from ¥8,576 million in the previous fiscal year to ¥8,007 million. - FY2021-Q3Decrease in cumulative SG&A expenses through the third quarter continuesAnnual report
「Selling, general and administrative expenses 6,401,510 5,982,037」
Cumulative SG&A expenses through the third quarter were ¥5,982 million, down ¥419 million from ¥6,401 million in the same period of the previous year. - FY2021-Q2Cumulative SG&A expenses through the second quarter decreasedAnnual report
「Selling, general and administrative expenses 4,235,814 3,895,372」
Cumulative SG&A expenses through the second quarter were ¥3,895 million, down ¥340 million from ¥4,235 million in the same period of the previous year. - FY2021-Q1SG&A expenses for the first quarter decreasedAnnual report
「Selling, general and administrative expenses 2,057,294 1,823,554」
SG&A expenses decreased by ¥234 million from ¥2,057 million in the same period of the previous year to ¥1,823 million. - FY2020-Q3RestatedAnnual report
「Selling, general and administrative expenses 6,457,752 6,401,510」
Cumulative SG&A expenses through the third quarter were ¥6,401 million, down ¥56 million from ¥6,457 million in the same period of the previous year. - FY2020-Q2Cumulative SG&A expenses through the second quarter decreasedAnnual report
「Operating profit exceeded that of the same quarter of the previous year because SG&A expenses decreased.」
In the environmental equipment business, lower SG&A expenses contributed to operating profit exceeding the same period of the previous year. Consolidated SG&A expenses also decreased from ¥4,283 million in the same period of the previous year to ¥4,235 million. - FY2019First statedAnnual report
「Selling, general and administrative expenses increased by ¥250 million from the previous consolidated fiscal year to ¥8,690 million due to higher personnel and R&D costs. However, operating profit increased by ¥130 million to ¥2,703 million, owing to higher gross profit.」
SG&A expenses increased by ¥250 million due to higher personnel and R&D-related costs, while operating profit increased by ¥130 million owing to higher gross profit.